| 【Company Research】China Life (2628 HK) - 4Q slowdown as expected; DPS exceeded >50% |
| 【Company Research】BOE Varitronix (710 HK) - FY24 strong sales dragged by weaker margin; system biz and overseas expansion as next growth drivers |
| 【Company Research】Giant Biogene (2367 HK) - Strong Performance in 2024 |
| 【Company Research】Weichai Power (2338 HK/000338 CH) - Strong engine margin expansion in 2024; 55% dividend payout ratio a record high |
| 【Company Research】Haidilao (6862 HK) - Potential store and margin expansion ahead |
| 【Company Research】Atour Lifestyle (ATAT US) - Cautious outlook but downside is limited |
| 【Company Research】WuXi Biologics (2269 HK) - Strong demand to drive growth acceleration in 2025 |
| 【Company Research】Nongfu Spring (9633 HK) - Flat FY24 earnings, with FY25 set for double-digit growth |
| 【Company Research】3SBio (1530 HK) - Earnings beat, rich pipeline promises future growth |
| 【Company Research】SenseTime (20 HK) - Gen AI business maintains momentum on increased AI investment |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
